Detalhe da pesquisa
1.
High-dose AraC is essential for the treatment of ML-DS independent of postinduction MRD: results of the COG AAML1531 trial.
Blood
; 138(23): 2337-2346, 2021 12 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34320162
2.
Comprehensive molecular and clinical characterization of NUP98 fusions in pediatric acute myeloid leukemia.
Haematologica
; 108(8): 2044-2058, 2023 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36815378
3.
Pathologic, cytogenetic, and molecular features of acute myeloid leukemia with megakaryocytic differentiation: A report from the Children's Oncology Group.
Pediatr Blood Cancer
; 70(5): e30251, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36789545
4.
Cytarabine dose reduction in patients with low-risk acute myeloid leukemia: A report from the Children's Oncology Group.
Pediatr Blood Cancer
; 69(1): e29313, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34472213
5.
Prognostic significance of chromosomal abnormalities at relapse in children with relapsed acute myeloid leukemia: A retrospective cohort study of the Relapsed AML 2001/01 Study.
Pediatr Blood Cancer
; 69(1): e29341, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34532968
6.
Prognostic impact of t(16;21)(p11;q22) and t(16;21)(q24;q22) in pediatric AML: a retrospective study by the I-BFM Study Group.
Blood
; 132(15): 1584-1592, 2018 10 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30150206
7.
Bortezomib with standard chemotherapy for children with acute myeloid leukemia does not improve treatment outcomes: a report from the Children's Oncology Group.
Haematologica
; 105(7): 1879-1886, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32029509
8.
Improved outcomes for myeloid leukemia of Down syndrome: a report from the Children's Oncology Group AAML0431 trial.
Blood
; 129(25): 3304-3313, 2017 06 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-28389462
9.
Genomic architecture and treatment outcome in pediatric acute myeloid leukemia: a Children's Oncology Group report.
Blood
; 129(23): 3051-3058, 2017 06 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28411282
10.
POST: A framework for set-based association analysis in high-dimensional data.
Methods
; 145: 76-81, 2018 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29777750
11.
Acquired centromeric heteromorphism of chromosome 7 yields discordant results between fluorescent in situ hybridization and karyotype analysis in a child with severe congenital neutropenia.
Pediatr Hematol Oncol
; 36(7): 432-437, 2019 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-31411529
12.
Phase 1 trial, pharmacokinetics, and pharmacodynamics of dasatinib combined with crizotinib in children with recurrent or progressive high-grade and diffuse intrinsic pontine glioma.
Pediatr Blood Cancer
; 65(7): e27035, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29512900
13.
Disease burden and conditioning regimens in ASCT1221, a randomized phase II trial in children with juvenile myelomonocytic leukemia: A Children's Oncology Group study.
Pediatr Blood Cancer
; 65(7): e27034, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29528181
14.
Hexosamine pathway regulates StarD7 expression in JEG-3 cells.
Mol Biol Rep
; 45(6): 2593-2600, 2018 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-30315445
15.
The genetic basis of early T-cell precursor acute lymphoblastic leukaemia.
Nature
; 481(7380): 157-63, 2012 Jan 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-22237106
16.
Heterogeneous cytogenetic subgroups and outcomes in childhood acute megakaryoblastic leukemia: a retrospective international study.
Blood
; 126(13): 1575-84, 2015 Sep 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-26215111
17.
Phenotype in combination with genotype improves outcome prediction in acute myeloid leukemia: a report from Children's Oncology Group protocol AAML0531.
Haematologica
; 102(12): 2058-2068, 2017 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-28883080
18.
Guideline for management of non-Down syndrome neonates with a myeloproliferative disease on behalf of the I-BFM AML Study Group and EWOG-MDS.
Haematologica
; 107(3): 759-764, 2022 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34854279
19.
NUP98/NSD1 and FLT3/ITD coexpression is more prevalent in younger AML patients and leads to induction failure: a COG and SWOG report.
Blood
; 124(15): 2400-7, 2014 Oct 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-25145343
20.
miR-155 expression and correlation with clinical outcome in pediatric AML: A report from Children's Oncology Group.
Pediatr Blood Cancer
; 63(12): 2096-2103, 2016 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-27511899